Your browser is no longer supported. Please, upgrade your browser.
Settings
NVAX Novavax, Inc. daily Stock Chart
NVAX [NASD]
Novavax, Inc.
Index- P/E- EPS (ttm)-1.03 Insider Own0.10% Shs Outstand274.13M Perf Week3.23%
Market Cap350.89M Forward P/E- EPS next Y-0.68 Insider Trans-24.51% Shs Float267.76M Perf Month-15.23%
Income-280.00M PEG- EPS next Q-0.17 Inst Own54.70% Short Float24.72% Perf Quarter-3.03%
Sales15.40M P/S22.78 EPS this Y-72.80% Inst Trans-13.52% Short Ratio10.80 Perf Half Y-43.86%
Book/sh-0.02 P/B- EPS next Y-9.70% ROA-56.80% Target Price3.29 Perf Year-75.10%
Cash/sh0.86 P/C1.49 EPS next 5Y0.00% ROE-329.60% 52W Range1.16 - 8.49 Perf YTD1.59%
Dividend- P/FCF- EPS past 5Y-43.40% ROI- 52W High-84.92% Beta2.00
Dividend %- Quick Ratio4.30 Sales past 5Y0.90% Gross Margin- 52W Low10.34% ATR0.07
Employees355 Current Ratio4.30 Sales Q/Q-8.50% Oper. Margin- RSI (14)42.93 Volatility4.32% 4.50%
OptionableYes Debt/Eq- EPS Q/Q27.90% Profit Margin- Rel Volume0.63 Prev Close1.29
ShortableYes LT Debt/Eq- EarningsFeb 27 AMC Payout- Avg Volume6.13M Price1.28
Recom2.70 SMA20-6.88% SMA50-7.35% SMA200-62.41% Volume3,847,900 Change-0.78%
Sep-20-16Reiterated Chardan Capital Markets Neutral $5.75 → $1.50
Sep-16-16Reiterated FBR & Co. Outperform $17 → $12
Sep-16-16Downgrade Wedbush Outperform → Neutral $14 → $2
Sep-16-16Downgrade Piper Jaffray Overweight → Neutral
Sep-16-16Downgrade Ladenburg Thalmann Buy → Neutral
Sep-16-16Downgrade JP Morgan Overweight → Neutral
Sep-16-16Downgrade Citigroup Buy → Neutral
Apr-04-16Initiated Chardan Capital Markets Neutral $5.75
Jul-09-15Reiterated Citigroup Buy $10 → $18
Jun-09-15Initiated Guggenheim Buy
Mar-11-14Reiterated Ladenburg Thalmann Buy $4 → $10
Oct-30-13Initiated FBR Capital Outperform $11
Sep-25-13Reiterated MLV & Co Buy $8.50 → $9.50
Mar-15-11Initiated Wedbush Outperform $6
Jun-15-10Initiated Dawson James Buy $4.50
Mar-15-10Initiated Roth Capital Buy $5
Dec-03-09Initiated Global Hunter Securities Buy $7.25
Dec-01-09Initiated Piper Jaffray Overweight $4.50
Nov-05-09Initiated Merriman Buy $7
Sep-02-09Downgrade Oppenheimer Outperform → Perform
Mar-27-17 04:02PM  ETFs with exposure to Novavax, Inc. : March 27, 2017
09:30AM  Biotech Industry Continues to Provide Investors with Gains in 2017: Today's Reports on Peregrine Pharmaceuticals and Novavax Accesswire
06:55AM  The 6 Most Shorted Nasdaq Stocks
Mar-21-17 08:22AM  3 Beaten-Up Biotech Stocks: Are They Bargains? at Motley Fool -7.58%
Mar-20-17 08:59AM  Novavax, Inc. :NVAX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
Mar-16-17 09:30AM  Trade Volume Can Speak a Lot About Momentum of a Stock Accesswire
Mar-14-17 02:50PM  Novavax, Inc. :NVAX-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
Mar-09-17 12:40PM  These 5 Stocks Under $10 Could Ignite Soon
07:47AM  These Popular Stocks Could Prove Toxic for Your Portfolio at Motley Fool
Mar-06-17 11:02AM  Why Novavax's Shares Marched Higher in February at Motley Fool
09:30AM  Biotech's Rally in 2017 Gaining Steam After President Trump's Speech: Today's Reports on BioScrip and Novavax Accesswire
Mar-03-17 01:04PM  NOVAVAX INC Financials
Feb-28-17 07:02PM  NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -7.36%
06:13PM  Here's Why Novavax, Inc.'s Share Price Went Down the Drain at Motley Fool
11:03AM  3 Stocks to Avoid in Biotech at Motley Fool
10:10AM  Novavax: 'We still expect to enjoy the advantage of being the first RSV vaccine' at bizjournals.com
09:45AM  Novavax Stock Spikes on Q4 Results at Investopedia
09:22AM  Biotech Premarket Movers: Cempra, Novavax, Ionis
Feb-27-17 05:26PM  Novavax reports 4Q loss +18.12%
05:06PM  NOVAVAX INC Files SEC form 10-K, Annual Report
04:30PM  Novavax Inc Earnings Call scheduled for 4:30 pm ET today
04:11PM  Novavax Reports Fourth Quarter and Year-End 2016 Financial Results GlobeNewswire
04:05PM  Novavax Reports Fourth Quarter and Year-End 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 Novavax Inc Earnings Release - After Market Close
Feb-20-17 04:06PM  Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017 GlobeNewswire
04:05PM  Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017 GlobeNewswire
Feb-16-17 01:10PM  Better Buy: Novavax, Inc. vs. Inovio Pharmaceuticals at Motley Fool
09:30AM  Biotech Industry Poised for a Breakout in 2017? Today's Reports on Evoke Pharma and Novavax Accesswire
Feb-14-17 08:28AM  Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : February 14, 2017
Feb-03-17 09:22AM  Cluster of Insider Buying at Clinical-Stage Vaccine Company, Massive Insider Selling at Analog Chip Giant, Plus Other Insider Trading at Insider Monkey
Jan-28-17 04:58PM  Can Novavax Stay Ahead of the Competition? at Motley Fool
Jan-27-17 07:53AM  Novavax, Inc. breached its 50 day moving average in a Bearish Manner : NVAX-US : January 27, 2017
Jan-24-17 09:26AM  Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo
Jan-19-17 05:00PM  Novavax starts new clinical trial in bid to prove failed RSV vaccine at bizjournals.com
04:06PM  Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults GlobeNewswire
04:05PM  Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults GlobeNewswire
Jan-17-17 09:56AM  Better Buy: Novavax, Inc. vs. Roche at Motley Fool
Jan-13-17 08:50AM  In Honor Of Friday The 13th, Here Are Some Of The Unluckiest Trades Of 2016
Jan-11-17 11:10PM  D.C.-area biotech stocks fall on Trump's tough talk on industry at bizjournals.com -5.59%
Jan-10-17 11:01AM  Novavax, Inc. Value Analysis (NASDAQ:NVAX) : January 10, 2017
Jan-09-17 07:18AM  Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : January 9, 2017
Jan-06-17 02:33PM  5 Stocks Setting Up for Big Breakouts
10:10AM  Novavax, Inc. Stock Sank 83% in 2016 -- Could 2017 Be Even Worse? at Motley Fool
Jan-05-17 08:06AM  Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
08:05AM  Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
06:30AM  Genocea Announces Positive 6-Month Results from GEN-003 Phase 2b Clinical Trial GlobeNewswire
Jan-03-17 02:35PM  ETFs with exposure to Novavax, Inc. : January 3, 2017
Dec-28-16 08:35AM  Are Options Traders Betting on a Big Move in Novavax (NVAX) Stock?
Dec-22-16 09:36AM  2016's Worst Clinical Failures at Motley Fool
Dec-21-16 12:39PM  ETFs with exposure to Novavax, Inc. : December 21, 2016
07:11AM  Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : December 21, 2016
Dec-13-16 11:45AM  Why Novavax (NVAX) Stock Might be a Great Pick
Dec-07-16 05:30AM  Here is What Hedge Funds Think About Novavax, Inc. (NVAX) at Insider Monkey -8.90%
Dec-06-16 04:19PM  Why Novavax Stock Crashed in November at Motley Fool +13.18%
04:06PM  Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference GlobeNewswire
04:05PM  Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference GlobeNewswire
01:19PM  Read This Before You Buy Biotech Stocks at Motley Fool
Dec-05-16 12:25PM  ETFs with exposure to Novavax, Inc. : December 5, 2016
Dec-02-16 01:17PM  The Worst Biotech Stocks of 2016 at Motley Fool +5.08%
Dec-01-16 10:47AM  3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017 at Motley Fool
Nov-30-16 10:18PM  5 Stocks Hedge Funds Are Betting Against Insiders at Insider Monkey
04:06PM  Novavax to Participate in the Citi 2016 Global Healthcare Conference GlobeNewswire
04:05PM  Novavax to Participate in the Citi 2016 Global Healthcare Conference GlobeNewswire
Nov-23-16 01:18PM  ETFs with exposure to Novavax, Inc. : November 23, 2016
Nov-22-16 04:28PM  A Strong Case for Selling Novavax, Inc. Stock at Motley Fool
04:07PM  Novavax to Present at the 28th Annual Piper Jaffray Healthcare Conference GlobeNewswire
04:05PM  Novavax to Present at the 28th Annual Piper Jaffray Healthcare Conference GlobeNewswire
11:19AM  Novavax, Inc. :NVAX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 22, 2016
Nov-20-16 07:26AM  Penny Stocks: 2 to Buy, 2 to Avoid at Motley Fool
Nov-18-16 02:50PM  Edited Transcript of NVAX earnings conference call or presentation 9-Nov-16 9:30pm GMT
Nov-16-16 04:06PM  NOVAVAX INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -5.15%
Nov-14-16 04:57PM  NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Nov-11-16 03:34PM  How the Zika virus could be a major bright spot for Novavax at bizjournals.com
01:42PM  Novavax continues to pursue RSV vaccines despite failed trial at bizjournals.com
09:12AM  The Likely Reason Why Novavax, Inc. Sank Another 26.9% in October at Motley Fool
Nov-10-16 12:15PM  Novavax Roiled by Massive Layoffs, 3Q Loss (NVAX) at Investopedia -17.65%
10:01AM  Twitter, Ulta, Metlife, and More: Heres Why These Five Stocks Are in the Spotlight at Insider Monkey
08:29AM  Why Novavax, Inc. Is Tanking Today at Motley Fool
Nov-09-16 08:18PM  Novavax to cut 30 percent of its workforce, retool its pipeline after failed drug trial at bizjournals.com +17.24%
05:55PM  [$$] Novavax to Cut 30% of Workforce at The Wall Street Journal
05:14PM  Novavax Posts Mixed Q3 Results, Announces Restructuring And Update On RSV Program
05:11PM  Novavax to lay off 30% of staff as losses double at MarketWatch
04:55PM  Novavax reports 3Q loss
04:30PM  Novavax Inc Earnings Call scheduled for 4:30 pm ET today
04:29PM  Novavax Announces Restructuring Along With Mixed Q3 Earnings
04:14PM  NOVAVAX INC Files SEC form 10-Q, Quarterly Report
04:09PM  Novavax cuts jobs to push ahead with respiratory vaccine for elderly
04:06PM  Novavax Reports Third Quarter 2016 Financial Results GlobeNewswire
04:05PM  Novavax Reports Third Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q3 2016 Novavax Inc Earnings Release - After Market Close
Nov-08-16 12:10PM  What to Look for in Novavax Earnings
Nov-06-16 10:25AM  Top 10 Earnings Coming This Week at 24/7 Wall St.
Nov-02-16 05:24PM  UPDATE -- Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016 GlobeNewswire -7.59%
05:09PM  UPDATE -- Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016 GlobeNewswire
04:06PM  Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016 GlobeNewswire
04:05PM  Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016 GlobeNewswire
Nov-01-16 01:13PM  4 Stocks I'd Avoid at All Costs at Motley Fool
Oct-31-16 10:24AM  4 lessons from Novavax's failed trial about the risks of vaccine work at bizjournals.com +5.56%
Oct-29-16 08:16AM  3 Stocks to Avoid in Biotech at Motley Fool
Oct-12-16 06:45AM  The 6 Most Shorted Nasdaq Stocks at 24/7 Wall St. -8.47%
Novavax, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. The company develops respiratory syncytial virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III development stage; older adults in Phase II development stage; and children six months to five years of age in Phase I development stage. It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YOUNG JAMES FDirectorMar 14Sale1.39100,000138,980175,000Mar 16 04:19 PM
Trizzino JohnSVP, Commercial OperationsJan 31Buy1.123,4013,80988,965Feb 02 04:13 PM
Herrmann John A IIISVP, General CounselJan 31Buy1.124,9605,5557,072Feb 02 04:12 PM
PHILLIPS BARCLAY ASVP, Chief Financial OfficerJan 31Buy1.121,6331,82911,612Feb 02 04:10 PM
Glenn Gregory MPresident, R&DDec 07Buy1.451,0001,4464,427Dec 07 04:29 PM
Trizzino JohnSVP, Commercial OperationsSep 22Buy2.1746,00099,82085,564Sep 23 05:21 PM
DOUGLAS RICHARDDirectorSep 21Buy1.72100,000172,010350,000Sep 22 04:26 PM
MCMANUS MICHAEL A JRDirectorSep 21Buy1.6130,00048,297247,590Sep 22 04:24 PM
Glenn Gregory MPresident, R&DSep 21Buy1.651,0001,6493,427Sep 22 04:20 PM
BOUDREAUX GAILDirectorSep 20Buy1.45100,000144,850200,000Sep 21 04:21 PM
PHILLIPS BARCLAY ASVP, Chief Financial OfficerJul 31Buy4.294221,8109,979Aug 02 06:17 PM
EVANS GARY CDirectorJun 06Sale6.5018,998123,487321,979Jun 07 04:14 PM
EVANS GARY CDirectorMay 24Sale5.4216,13487,495340,977May 25 04:41 PM
EVANS GARY CDirectorMay 23Sale5.4033,866182,876357,111May 25 04:41 PM
Erck Stanley CPresident and CEOMar 31Option Exercise1.28201,991258,548305,048Apr 01 05:34 PM
Erck Stanley CPresident and CEOMar 31Sale5.18226,7691,175,61678,279Apr 01 05:34 PM